Important Information About Immunotherapy Therapy Called Checkpoint Inhibitors
Posted on: November 3, 2023 *Updated on: May 27, 2024Immunotherapy has emerged as a significant approach in the treatment of mesothelioma. One notable category within immunotherapy is checkpoint inhibitors, which play a pivotal role in blocking the evasion of cancer cells from the immune system.
Checkpoint inhibitors target specific proteins responsible for regulating immune responses, such as PD-1 and CTLA-4. By inhibiting these checkpoints, these drugs enable the immune system to recognize and combat cancer cells more effectively.
However, it’s important to recognize that while checkpoint inhibitors have demonstrated efficacy, their success might vary depending on the individual and the type of mesothelioma. Ongoing research is dedicated to refining their application and investigating complementary immunotherapeutic strategies to maximize their benefits.
Always consult with your medical team, oncologist or primary care physician before starting any therapies.